Category Archives: sebio

SEBIO Conference: Sharklet Chomps the Shootout

medtechthursday
Guest Post by:
Mike Schmitt, MD
Life Science Analyst and Editor of the Florida BioDatabase
Mike can be reached at [email protected]

sharklet

The annual Southeast BIO Conference (SEBIO) meeting wrapped up several weeks ago in Palm Beach on December 5th.  I was not able to attend due to prior family commitments up north…and by the way—I just returned from a foot of snow in Buffalo—an experience that jogged my memory as to why I live in Florida (I’ll take a jab at my upstate NY friends now, before they once again remind me of hurricane season in June).

Readers may remember I’ve previously written about SEBIO which is a non-profit public/private partnership to promote the development of the life sciences throughout the Southeast.

Florida had 7 companies present at the meeting in addition to having technologies from the University of Florida as well as Florida International University compete in the BIO/Plan Competition.

Of the Early-Stage conference participants (primarily those with no prior institutional funding), 4 of the best companies were selected for an Early-Stage “Shootout” where they had a chance to do a full presentation to all of the investors attending the forum.

I’m happy to say that for the second year in a row, Florida has won the “Shootout” with Sharklet Technologies.  I should also mention that both Sharklet as well as last years “Shootout” winner, Transgeneron Therapeuticsare current residents of the University of Florida Sid Martin Biotech Incubator.  Transgeneron also appeared at this years meeting as a Main-Stage presenter. Needless to say, this reflects well on Florida and the Sid Martin Incubator—congratz to David Day, Patti Breedlove and Jane Muir!

Sharklet is a biotechnology company that develops and brings to market surface technologies (inspired by the antimicrobial properties of shark skin) that are designed to inhibit or enhance microorganism growth to make the world a healthier and safer place.

“We are delighted to have been selected as the winner of the SEBIO Early-Stage Shootout as the win validates that there is significant interest in Sharklet and a pressing need for an environmentally friendly and no-kill strategy for bacterial control in the healthcare market,” said Joe Bagan, Sharklet Technologies’ chief executive officer.

The BIO/Plan Competition (which is intended to identify and support newly created venture-fundable entities in the life sciences) had 10 finalists this year with 3 involving Florida technologies (a good showing). 

This is no small deal as the winner was awarded unrestricted, non-dilutive venture funds (valued at $100,000 in cash and services) to launch the enterprise and implement their business plan.

Here are the 3 from Florida (I don’t think that any of these very early entities have websites yet).

Cardiac BioSolutionsA device company developing revolutionary percutaneous heart valve (PHV) products, such as a more durable artificial aortic valve with the beneficial properties of a natural tissue valve, and a catheter delivery system which can be used with any percutaneous valve (Florida International University).

RibotheronA discovery stage company employing hammerhead ribozymes that block replication of herpes viruses I and II as a novel anti-HSV therapy, initially for corneal infections (University of Florida).

NeuroPoetixA new drug development company that combines insights and advances in stem cell biology and knowledge about the central nervous system (CNS) to significantly progress the development of drugs to treat serious diseases of the brain (University of Florida).

The winner of the BIO/Plan competition was Cerene Biomedics, from North Carolina.

Cerene BiomedicsA device company developing an implantable device to prevent focal epileptic seizures by delivering targeted thermoelectric cooling to the neocortex, anticipated to be first line therapy for many patients suffering from uncontrolled seizures (Duke University).

For the very early stage life science entrepreneurs, it’s time to start thinking ahead as the BIO/Plan application process usually begins in February of each year.  Readers can check out further details at the SEBIO website.

Free Money for Life Science Entrepreneurs

medtechthursday
Guest Post by:
Mike Schmitt, MD
Life Science Analyst and Editor of the Florida BioDatabase
Mike can be reached at [email protected]

sebio

“Free Money” for life science entrepreneurs with up to $100,000 in cash and services!

Now that I have your full attention (I had to get a “hook” in there somewhere—the money may not be totally “free”, but it’s a great deal as start ups go), I’d like to tell you about the SEBIO sponsored annual “Bio/Plan Competition.”

Last post I mentioned the upcoming Southeast BIO (SEBIO) Conference to be held on December 4-5, 2008 in Palm Beach. For those not familiar with this organization, SEBIO is a non-profit public/private partnership to promote the development of the life sciences throughout the Southeast.

One of the exciting events at this conference is the announcement of the winner of the annual Bio/Plan Competition.

This is intended to identify and support newly created venture-fundable entities in the life sciences (the majority of the applicants are from research universities and research labs throughout the Southeast).

Here is how it works…(from the SEBIO website):

  1. The principal investigator/entrepreneur completes a short application outlining their concept and the associated opportunity in broad terms. There is no application fee.
  2. A selection committee chooses 10 semifinalists and pairs each with a team of seasoned professionals who will serve as mentors to the principals. The group’s goal will be to further develop the concept and surround it with a first-class business plan.
  3. Following a period of 5 to 6 months with the assigned mentoring team, a finished business plan will be submitted by the principals to a panel of experts and 4 finalists will be selected. These finalists will present their opportunity to the broader life science investment community at the annual SEBIO Investor Forum held each fall.
  4. The winner of the BIO/Plan Competition will be selected at this Conference and will be awarded unrestricted, non-dilutive venture funds (valued at $100,000 in cash and services) to launch the enterprise and implement their business plan.

In the past, the application process began in February. It’s not too early to start thinking ahead. Readers can check out further details at the SEBIO website (www.sebio.org/bioplan).

SEBIO Update: Florida Catches North Carolina

medtechthursday
Guest Post by:
Mike Schmitt, MD
Life Science Analyst and Editor of the Florida BioDatabase
Mike can be reached at [email protected]      

Florida is ready to make a good impression at the upcoming Southeast BIO (SEBIO) Conference to be held on December 4-5, 2008 in Palm Beach.  SEBIO is a non-profit public/private partnership to promote the development of the life sciences throughout the Southeast.

Our State has tied North Carolina (this has not happened in recent years that I’m  aware of) with each State having 8 companies selected for the conference (actually, Florida shares an additional company in that NC based Pique Therapeutics has R&D activities in Miami).  Overall, SEBIO has selected 29 companies to participate in this year’s forum.

The conference offers an “early stage” event focused on newly emerging companies along with a “presenting” companies event for those ventures that have completed at least one round of institutional funding.  Public companies are not included in the forum.

This can be an excellent learning opportunity as early stage participants receive direct feed back from venture capitalists and business advisors as they go through the conference process.  Ultimately, 4 of the best are selected for an “Early-Stage Shootout” where they will have a chance to do a full presentation to all of the investors attending the forum.

Selected Presenting Companies of interest to Florida are:

 Selected Early-Stage Florida Companies are:

Since 2005, there have been 15 Florida life science companies that have presented at SEBIO with over $117M raised among this group alone during the past 3 years (this does not include the 2008 participants).  This is an excellent opportunity to gain visibility as well as making a possible connection for VC funding (VC firms from throughout the US have attended including the Southeast, Midwest, West Coast as well as the Northeast regions).